The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance

Current Opinion in Oncology

Volumn 12, Issue 6, 2000, Pages 557-563

  Shain, Kenneth H ^a   Landowski, Terry H ^a   Dalton, William S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; GROWTH FACTOR; INTEGRIN; MELPHALAN;

BONE MARROW CELL; CANCER CELL; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENE REARRANGEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TARGET CELL;

ANTIGENS, CD95; BONE MARROW; CELL ADHESION; CELL DEATH; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; INTEGRINS; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0034501628     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200011000-00008     Document Type: Review

References (74)

1. The distribution of secondary growths in cancer of the breast
2. Survival by Mac-l-mediated adherence and anoikis in phorbol ester-treated HL-60 cells
3. Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis
4. Multiple myeloma: Increasing evidence for a multistep transformation process
5. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma
6. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266
7. Myeloma biology and therapy: Present status and future developments
8. Signal transduction pathways that regulate cell survival and cell death
9. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
10. IL-6 triggers cell growth via the ras-dependent mitogen-activated protein kinase cascade
11. Interleukin-6 inhibits fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells
12. Interleukin-6 prevents dexamethasone-induced myeloma cell death
13. Interleukin-6 inhibits apoptosis of malignant plasma cells
14. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
15. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma
16. Cytokines, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma
17. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients
18. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
19. Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines
20. Role of cell shape in growth control
21. Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma
22. Disruption of epithelial cell-matrix interactions induces apoptosis
23. The extracellular matrix as a cell survival factor
24. Two transcription factors, NF-KB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter
25. Integrins and anoikis
26. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression
27. Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation
28. Matrix survival signaling: From fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase
29. Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism
30. Adhesion to fibronectin prolongs eosinophil survival
31. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: Correlation with Bcl-2 and Bax
32. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes
33. Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells
34. Effects of extracellular matrix on the response of endothelial cells to radiation in vitro
35. Signaling by integrin receptors
36. Integrins and signal transduction pathways: The road taken
37. Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules
38. Integrin signaling: Specificity and control of cell survival and cell cycle progression
39. Interaction of focal adhesion kinase with cytoskeletal protein talin
40. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk
41. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding
42. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: A role for Src family kinases
43. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression
44. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: Involvement of the Grb2, p130cas, and Nck adaptor proteins
45. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src
46. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
47. Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas
48. PI3K: Downstream AKTion blocks apoptosis
49. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
50. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
51. Regulation of cell death protease caspase-9 by phosphorylation
52. Integrin-mediated activation of MAP kinase is independent of FAK: Evidence for dual integrin signaling pathways in fibroblasts
53. Cleavage of focal adhesion kinase by caspases during apoptosis
54. Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells
55. Cell contact as a possible contribution to radiation resistance of some tumours
56. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
57. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors
58. Integrin-mediated drug resistance in multiple myeloma
59. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
60. Cellular adhesion to fibronectin protects the RPMI 8226 and the U937 cancer cell lines from CD95-mediated apoptosis
61. The role of adhesion molecules in multiple myeloma
62. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
63. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: Evidence for independent mechanisms of caspase activation
64. Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy mediated apoptosis in the RPMI 8226 multiple myeloma cell line
65. Drug-induced apoptosis is associated with enhanced Fas (APO-1/CD95) ligand expression but occurs independently of Fas (APO-1/CD95) signaling in human T-acute lymphatic leukemia cells
66. Involvement of the CD95 (APO-1/fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
67. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
68. Apoptosis by death factor
69. An induced proximity model for caspase-8 activation
70. Two CD95 (APO-1/Fas) signaling pathways
71. Caspase-dependent cleavage of signaling proteins during apoptosis: A turn-off mechanism for anti-apoptotic signals
72. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo
73. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis
74. Involvement of FADD and caspase signalling in detachment-induced apoptosis